M
Mario Guidotti
Publications - 18
Citations - 388
Mario Guidotti is an academic researcher. The author has contributed to research in topics: Stroke & Frovatriptan. The author has an hindex of 11, co-authored 18 publications receiving 321 citations.
Papers
More filters
Journal ArticleDOI
MMP9 Variation After Thrombolysis Is Associated With Hemorrhagic Transformation of Lesion and Death
Domenico Inzitari,Betti Giusti,Patrizia Nencini,Anna Maria Gori,Mascia Nesi,Vanessa Palumbo,Benedetta Piccardi,Alessandra Armillis,Giovanni Pracucci,Giorgio Bono,Paolo Bovi,Domenico Consoli,Mario Guidotti,Antonia Nucera,Francesca Massaro,Giuseppe Micieli,Giovanni Orlandi,Francesco Perini,Rossana Tassi,Maria Rosaria Tola,Maria Sessa,Danilo Toni,Rosanna Abbate +22 more
TL;DR: Clinical evidence corroborates the detrimental role of matrix metalloproteinase-9 during ischemic stroke treated with thrombolysis, and prompts clinical trials testing agents antagonizing its effects.
Journal ArticleDOI
Air pollution positively correlates with daily stroke admission and in hospital mortality: a study in the urban area of Como, Italy.
TL;DR: An association between short-term outdoor air pollution exposure and ischemic stroke admission and mortality in an urban population is suggested.
Journal ArticleDOI
Frovatriptan vs. transdermal oestrogens or naproxen sodium for the prophylaxis of menstrual migraine.
TL;DR: It is suggested that short-term prophylaxis of MM with frovatriptan may be more effective than that based on transdermal oestrogens or naproxen sodium.
Journal ArticleDOI
Inflammatory and metalloproteinases profiles predict three-month poor outcomes in ischemic stroke treated with thrombolysis.
Anna Maria Gori,Betti Giusti,Benedetta Piccardi,Patrizia Nencini,Vanessa Palumbo,Mascia Nesi,Antonia Nucera,Giovanni Pracucci,Paolina Tonelli,Eleonora Innocenti,Alice Sereni,Elena Sticchi,Danilo Toni,Paolo Bovi,Mario Guidotti,Maria Rosaria Tola,Domenico Consoli,Giuseppe Micieli,Rossana Tassi,Giovanni Orlandi,Maria Sessa,Francesco Perini,Maria Luisa DeLodovici,Marialuisa Zedde,Francesca Massaro,Rosanna Abbate,Domenico Inzitari +26 more
TL;DR: Among AIS patients treated with thrombolysis, circulating A2M, SAP and Δmetalloproteinase 9 are independent markers of poor outcome, and these results may prompt controlled clinical research about agents antagonizing their effect.
Journal ArticleDOI
Clinical Pregenetic Screening for Stroke Monogenic Diseases: Results From Lombardia GENS Registry
Anna Bersano,Hugh S. Markus,Silvana Quaglini,Eloisa Arbustini,Silvia Lanfranconi,Giuseppe Micieli,Giorgio B. Boncoraglio,Franco Taroni,C. Gellera,Silvia Baratta,Silvana Penco,Lorena Mosca,Maurizia Grasso,Paola Carrera,Maurizio Ferrari,Cristina Cereda,Gaetano S. Grieco,Stefania Corti,Dario Ronchi,Maria Teresa Bassi,Laura Obici,Eugenio Parati,Alessando Pezzini,Maria Luisa De Lodovici,Elena Pinuccia Verrengia,Giorgio Bono,Francesca Mazucchelli,Davide Zarcone,Maria Vittoria Calloni,Patrizia Perrone,Bianca Maria Bordo,Antonio Colombo,Alessandro Padovani,Anna Cavallini,Simone Beretta,Carlo Ferrarese,Cristina Motto,Elio Agostoni,Graziella Molini,Francesco Sasanelli,Manuel Corato,Simona Marcheselli,Maria Sessa,Giancarlo Comi,Nicoletta Checcarelli,Mario Guidotti,Davide Uccellini,Erminio Capitani,Lucia Tancredi,Marco Arnaboldi,Barbara Incorvaia,Carlo Sebastiano Tadeo,Laura Fusi,Giampiero Grampa,Giampaolo Merlini,Nadia Trobia,Giacomo P. Comi,Massimiliano Braga,Paolo Vitali,Pierluigi Baron,Caspar Grond-Ginsbach,Livia Candelise +61 more
TL;DR: In patients prescreened using a clinical algorithm for monogenic disorders, monogenic causes of events were identified in 7% of patients in comparison to the 1% to 5% prevalence reported in previous series.